-The Times of India MUMBAI: Turf war between Big Pharma and generic companies, which was largely restricted to exorbitantly priced life-saving drugs for cancer and HIV, is now spilling over to other chronic ailments like diabetes, and threatening to change dynamics of the nearly Rs 70,000 crore Indian pharma market. Triggering a full-blown patent fight with US-based Merck, domestic generic company Glenmark has launched a more affordable version of the multinational's blockbuster...
More »SEARCH RESULT
Total Matching Records found : 231
‘Herbal medicines causing kidney failure, bladder cancer in India’ -Kounteya Sinha
-The Times of India LONDON: Herbal medicines are causing millions in India to develop kidney failure and bladder cancer. In a warning that is bound to cause a fresh row over the quality of Asian herbal medicines, British scientists were due to announce on Tuesday that millions of people in Asia — specially in India and China — might be exposed to the risk of kidney failure and bladder cancer from taking...
More »Brinda demands independent probe-Sarabjit Pandher
-The Hindu Communist Party of India (Marxist) Polit Bureau member Brinda Karat on Wednesday demanded an independent inquiry into the Comptroller and Auditor General (CAG) report, which has pointed out serious lapses and wrongdoings in the Rs. 52,000-crore farm debt waiver scheme. Ms. Karat was talking to journalists at the party office here, before resuming her programme of “Sangharsh Sandesh Jatha,” which began from Jallianwala Bagh in Amritsar on March 4. She said...
More »Natco Pharma wins cancer drug case-R Sivaraman
-The Hindu Bayer's plea dismissed by the Intellectual Property Appellate Board The Intellectual Property Appellate Board (IPAB) on Monday upheld the grant of compulsory licence (CL) to the Hyderabad-based Natco Pharma Limited, a generic drug maker, to produce and market Nexavar, a patented cancer drug of multinational pharma major Bayer Corporation. The order will pave the way for reduction in the prices of costly life saving drugs. Disposing an appeal filed by Bayer...
More »Child cancer victims need a helping hand-Anuradha Mascarenhas
-The Indian Express At a time when targeted therapies work like magic bullets killing cancer cells and sparing normal ones, only 15-20 per cent child victims of the disease are treated in India due to lack of diagnosis and access to treatment. With cancer affecting approximately 60,000 children in the country annually, the Lancet Oncology series released Tuesday is a wake-up call to the government to deal with the challenge of...
More »
